(Q36353473)

13 August 2017

1 reference

title

Pathogen inactivation techniques (English)

1 reference

13 August 2017

Pelletier JP

1

1 reference

PubMed ID

16377551

13 August 2017

Transue S

series ordinal

2

1 reference

PubMed ID

16377551

13 August 2017

Snyder EL

series ordinal

3

1 reference

13 August 2017

1 January 2006

1 reference

Best Practice and Research: Clinical Haematology

13 August 2017

1 reference

13 August 2017

19

1 reference

13 August 2017

1

1 reference

13 August 2017

205-242

1 reference

Viral safety of haemophilia treatment products

13 August 2017

1 reference

12 December 2020

Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light

1 reference

12 December 2020

Riboflavin and UV-light based pathogen reduction: extent and consequence of DNA damage at the molecular level.

1 reference

12 December 2020

Virus validation studies of immunoglobulin preparations.

1 reference

12 December 2020

The use of dimethylmethylene blue for virus photoinactivation of red cell suspensions

1 reference

12 December 2020

Viral safety of blood derivatives by immune neutralization

1 reference

12 December 2020

Reducing the risk of blood transfusion.

1 reference

12 December 2020

Progress in improving the pathogen safety of red cell concentrates.

1 reference

12 December 2020

Safety and cost-effectiveness of solvent-detergent-treated plasma. In search of a zero-risk blood supply

1 reference

12 December 2020

West Nile virus in blood: stability, distribution, and susceptibility to PEN110 inactivation

1 reference

12 December 2020

Pathogen reduction of buffy coat platelet concentrates using riboflavin and light: comparisons with pathogen-reduction technology-treated apheresis platelet products.

1 reference

12 December 2020

Current clinical and preclinical photosensitizers for use in photodynamic therapy

1 reference

12 December 2020

Separation, identification and quantification of riboflavin and its photoproducts in blood products using high-performance liquid chromatography with fluorescence detection: a method to support pathogen reduction technology

1 reference

12 December 2020

Inactivation of mycoplasma species in blood by INACTINE PEN110 process.

1 reference

12 December 2020

Inhibition of murine GVHD by PEN110 treatment

1 reference

12 December 2020

Prevention of Yersinia enterocolitica, Pseudomonas fluorescens, and Pseudomonas putida outgrowth in deliberately inoculated blood by a novel pathogen-reduction process.

1 reference

12 December 2020

Influence of methylene blue photoinactivation treatment on coagulation factors from fresh frozen plasma, cryoprecipitates and cryosupernatants.

1 reference

12 December 2020

Pharmacokinetic study of FFP photochemically treated with amotosalen (S-59) and UV light compared to FFP in healthy volunteers anticoagulated with warfarin

1 reference

12 December 2020

Photosensitized inactivation of ribonucleic acids in the presence of riboflavin.

1 reference

12 December 2020

Inactivation of Gram-negative and Gram-positive bacteria in red cell concentrates using INACTINE PEN110 chemistry.

1 reference

12 December 2020

A randomized trial of solvent/detergent-treated and standard fresh-frozen plasma in the coagulopathy of liver disease and liver transplantation.

1 reference

12 December 2020

Efforts in minimizing risk of viral transmission through viral inactivation

1 reference

12 December 2020

Methylene blue directly oxidizes glutathione without the intermediate formation of hydrogen peroxide.

1 reference

12 December 2020

Production of pathogen-inactivated RBC concentrates using PEN110 chemistry: a Phase I clinical study

1 reference

12 December 2020

Inactivation of WBCs in RBC suspensions by photoactive phenothiazine dyes: comparison of dimethylmethylene blue and MB.

1 reference

12 December 2020

Development of a sensitive PCR inhibition method to demonstrate HBV nucleic acid inactivation.

1 reference

12 December 2020

Efficacy of SD-treated plasma during liver transplantation

1 reference

12 December 2020

Effects of solvent/detergent-treated plasma and fresh-frozen plasma on haemostasis and fibrinolysis in complex coagulopathy following open-heart surgery

1 reference

12 December 2020

Binding affinities of commonly employed sensitizers of viral inactivation

1 reference

12 December 2020

Assessment of the genotoxic potential of riboflavin and lumiflavin. A. Effect of metabolic enzymes

1 reference

12 December 2020

Viral inactivation of fresh frozen plasma

1 reference

12 December 2020

Inactivation of viruses in fresh-frozen plasma

1 reference

12 December 2020

Inhibition of xenogeneic GVHD by PEN110 treatment of donor human PBMNCs.

1 reference

12 December 2020

Hepatitis C virus and blood transfusion: past and present risks

1 reference

12 December 2020

Preclinical safety profile of plasma prepared using the INTERCEPT Blood System

1 reference

12 December 2020

Trypanosoma cruzi inactivation in human platelet concentrates and plasma by a psoralen (amotosalen HCl) and long-wavelength UV.

1 reference

12 December 2020

Inactivation of HIV in blood

1 reference

12 December 2020

The SOS Chromotest, a colorimetric bacterial assay for genotoxins: procedures

1 reference

12 December 2020

Virus inactivation of fresh plasma

1 reference

12 December 2020

Inactivation of viruses, bacteria, protozoa and leukocytes in platelet and red cell concentrates.

1 reference

12 December 2020

Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light

1 reference

12 December 2020

The use of dyes in modern biomedicine

1 reference

12 December 2020

Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial

1 reference

12 December 2020

Virus inactivation of fresh frozen plasma by a solvent detergent procedure: biological results

1 reference

12 December 2020

Fundamentals of the psoralen-based Helinx technology for inactivation of infectious pathogens and leukocytes in platelets and plasma

1 reference

12 December 2020

Methylene blue derivatives--suitable photoantimicrobials for blood product disinfection?

1 reference

12 December 2020

Helinx technology for inactivation of infectious pathogens and leukocytes in labile blood components: from theory to clinical application

1 reference

12 December 2020

Virally inactivated fresh frozen plasma

1 reference

12 December 2020

Virus inactivation by solvent/detergent treatment and the manufacture of SD-plasma

1 reference

12 December 2020

Methylene blue photoinactivation of RNA viruses.

1 reference

12 December 2020

SD Plasma in TTP and coagulation factor deficiencies for which no concentrates are available

1 reference

12 December 2020

Universal solvent/detergent-treated fresh frozen plasma (Uniplas--rationale and clinical properties

1 reference

12 December 2020

Inactivation of protozoan parasites in red blood cells using INACTINE PEN110 chemistry.

1 reference

12 December 2020

Universal fresh frozen plasma (Uniplas): a safe product in open-heart surgery

1 reference

12 December 2020

Virus inactivation of blood products by phenothiazine dyes and light

1 reference

12 December 2020

Methylene blue photosensitised strand cleavage of DNA: effects of dye binding and oxygen

1 reference

12 December 2020

Photochemical treatment of platelet concentrates with amotosalen hydrochloride and ultraviolet A light inactivates free and latent cytomegalovirus in a murine transfusion model

1 reference

12 December 2020

Comparison of the DNA-damaging property of photosensitised riboflavin via singlet oxygen (1O2) and superoxide radical O2-. mechanisms.

1 reference

12 December 2020

Pathogen inactivation in blood products

1 reference

12 December 2020

Induction of latent human cytomegalovirus by conventional gamma irradiation and prevention by treatment with INACTINE PEN110.

1 reference

12 December 2020

Current strategies on pathogen removal/inactivation: an overview

1 reference

12 December 2020

Clinical studies with solvent detergent-treated products

1 reference

12 December 2020

Pathogen inactivation of RBCs: PEN110 reproductive toxicology studies

1 reference

12 December 2020

Viral reduction techniques: types and purpose

1 reference

12 December 2020

In vitro evaluation of pooled buffy coat platelets treated with photochemical pathogen inactivation using amotosalen

1 reference

12 December 2020

Investigation of photosensitizing dyes for pathogen reduction in red cell suspensions

1 reference

12 December 2020

Update of cost-effectiveness analysis for solvent-detergent-treated plasma

1 reference

12 December 2020

Inactivation of cytomegalovirus in platelet concentrates using Helinx technology

1 reference

12 December 2020

Prevention of transfusion-associated graft-versus-host disease by photochemical treatment

1 reference

12 December 2020

Pharmacokinetics of orally and intravenously administered riboflavin in healthy humans

1 reference

12 December 2020

A potentially improved approach to methylene blue virus inactivation of plasma: the Maco Pharma Maco-Tronic system

1 reference

12 December 2020

Functional characteristics of photochemically treated platelets

1 reference

12 December 2020

Solvent/detergent treatment of human plasma--a very robust method for virus inactivation. Validated virus safety of OCTAPLAS.

1 reference

12 December 2020

Recovery and life span of 111indium-radiolabeled platelets treated with pathogen inactivation with amotosalen HCl (S-59) and ultraviolet A light

1 reference

12 December 2020

A randomized trial of solvent/detergent and standard fresh frozen plasma in the treatment of the coagulopathy seen during Orthotopic Liver Transplantation

1 reference

12 December 2020

Cost-effectiveness of transfusing virus-inactivated plasma instead of standard plasma

1 reference

12 December 2020

Process for the preparation of pathogen-inactivated RBC concentrates by using PEN110 chemistry: preclinical studies

1 reference

12 December 2020

Methylene-blue-photoinactivated plasma and its contribution to blood safety

1 reference

12 December 2020

Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria

1 reference

12 December 2020

In vitro evaluation of COM.TEC apheresis platelet concentrates using a preparation set and pathogen inactivation over a storage period of five days

1 reference

12 December 2020

Current viral risks of blood and blood products

1 reference

12 December 2020

Estimated risk of transmission of the West Nile virus through blood transfusion in the US, 2002.

1 reference

12 December 2020

FDA approach to evaluation of pathogen reduction technology

1 reference

12 December 2020

Involvement of reactive oxygen species in hemoglobin oxidation and virus inactivation by 1,9-dimethylmethylene blue phototreatment

1 reference

12 December 2020

PEN110 treatment functionally inactivates the PBMNCs present in RBC units: comparison to the effects of exposure to gamma irradiation

1 reference

12 December 2020

The role of toxicology assessment in transfusion medicine

1 reference

12 December 2020

Broad-spectrum virus reduction in red cell concentrates using INACTINE PEN110 chemistry

1 reference

12 December 2020

In vitro characterization of solvent/detergent-treated human plasma and of quarantine fresh frozen plasma

1 reference

12 December 2020

FDA perspective on and response to the risk of hepatitis A from blood products

1 reference

12 December 2020

Resistance of vaccinia virus to inactivation by solvent/detergent treatment of blood products

1 reference

12 December 2020

Quinacrine enhances vesicular stomatitis virus inactivation and diminishes hemolysis of dimethylmethylene blue-phototreated red cells

1 reference

12 December 2020

Safety of the blood supply: role of pathogen reduction

1 reference

12 December 2020

Effectiveness of alternative treatments for reducing potential viral contaminants from plasma-derived products

1 reference

12 December 2020

Incidence of human parvovirus B19 DNA detection in blood donors

1 reference

12 December 2020

Revised methods for the Salmonella mutagenicity test

1 reference

12 December 2020

Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial

1 reference

12 December 2020

10.1016/J.BEHA.2005.04.001

Identifiers

DOI

1 reference

13 August 2017

0 references

1 reference

PubMed ID

16377551